This site is intended for healthcare professionals only
LoginRegister
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon receives over Rs 3 crore penalty over GST related issues
USFDA Approves Bionpharmas Generic HIV Drug EtravirineOrchid Pharma bags USFDA nod for Enmetazobactam
Health InfrastructureMorepen Labs receives board approval to raise up to Rs 350 crore
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsUSFDA completes inspections at Suven Pharma facilities with no form 483
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Gets CDSCO Panel nod to study Anti-cancer Drug Datopotamab Deruxtecan and Durvalumab
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureDupixent application accepted for priority review by USFDA for COPD with type 2 inflammation
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein...
ZydusZydus Lifesciences incorporates wholly owned subsidiary company in UAE
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreAstraZeneca completes acquisition of Gracell Biotechnologies
Novavax settles dispute with GaviNovavax settles dispute with Gavi
Cipla slapped over Rs 1 crore fine by GST AuthorityCDSCO Panel grants Cipla's Prescribing Information update for Bovine Lipid Extract Surfactant...
CiplaCipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions
X